SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla informs about loss of share certificate

07 Aug 2021 Evaluate
In compliance with the requirements of Regulation 39 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, vide intimation dated 29th July, 2021 we had submitted information about the request for issuance of duplicate share certificate in lieu of the loss of original share certificate by a shareholder, Cipla has informed that with the approval of the Stakeholders Relationship Committee, on 4th August, 2021, the Company has cancelled the original share certificate no. 500346 and has issued the duplicate share certificate.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1232.90 4.00 (0.33%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×